Abonements par 2 €

Par 2 € nodrošiniet

Financial Data API

Terminal Financial Data API

Ocular Therapeutix Aktie News & Pressemeldungen

Ocular Therapeutix Eulerpool Ziņas

13.09.2024. 14:49:38

Opaleye Management reduziert Beteiligung an Protara Therapeutics: Strategie oder Sorge?

13.09.2024. 13:04:46

Opaleye Management verstärkt Engagement in Eton Pharmaceuticals

1

1

Ocular Therapeutix Akciju Ziņas

Ocular Therapeutix tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Ocular Therapeutix ziņas mēs apkopojam šeit.

6. novembris ·
Yahoo
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024
1. novembris ·
GuruFocus
Opaleye Management Inc. Expands Stake in SANUWAVE Health Inc.
22. oktobris ·
GuruFocus
Opaleye Management Inc. Acquires New Stake in SANUWAVE Health Inc.
22. oktobris ·
TipRanks
Piper Sandler Remains a Buy on Ocular Therapeutix (OCUL)
20. oktobris ·
Thefly.com
Ocular Therapeutix management to meet with Piper Sandler
17. oktobris ·
TipRanks
Optimistic Buy Rating for Ocular Therapeutix Amid Accelerated SOL-1 Study Progress
16. oktobris ·
Thefly.com
Ocular Therapeutix initiated with bullish view at Scotiabank, here's why
16. oktobris ·
TipRanks
Ocular Therapeutix’s Promising Clinical Advancements and Strategic Trials Drive Buy Rating
16. oktobris ·
TipRanks
Buy Rating on Ocular Therapeutix: Accelerated Phase 3 Trial Enrollment and Promising 2025 Outlook
15. oktobris ·
Yahoo
Ocular Therapeutix™ Announces Accelerated Timelines for SOL-1 Registrational Trial of AXPAXLI™ in Wet AMD

1

2

1

2

Ocular Therapeutix akciju preses relīzes

Ocular Therapeutix regulāri publicē uzņēmuma tīmekļa vietnē ziņojumus, kas ir svarīgi investoriem.

Veic labākos ieguldījumus savā dzīvē

Par 2 € nodrošiniet